Block and Erector Comparative Study Between Costotransverse Spinae Plane Block in Patients Undergoing Thoracotomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2024-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A thoracotomy requires a very painful incision, involving multiple muscle layers, rib resection and continuous motion as the patient breathes. Treatment of acute post thoracotomy pain is particularly important not only to keep the patient comfortable but also to minimize pulmonary complications

Though epidural analgesia was once considered as the gold standard for post-thoracotomy pain management, it is not recommended for pain control after thoracotomy surgery because it is associated with high potential risks of dural puncture, nerve lesions, epidural hematoma and hypotension(4). Thoracic paravertebral block (TPVB) and intercostal nerve block are well described and recognized techniques for postoperative analgesia following thoracic surgeries, such as thoracotomy and mastectomy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery

NCT06529432

Local Analgesia Via Nerve Block

NOT_YET_RECRUITING PHASE2

Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine

NCT07134660

Postoperative Pain, Acute Lung Cancer

NOT_YET_RECRUITING NA

Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy

NCT06313632

Pleural Disease Postoperative Pain

TERMINATED PHASE3

Comparison of Thoracolumbar Interfascial and Erector Spinae Plane Block on Analgesic Efficiency of After Spinal Surgery

NCT03931343

Postoperative Pain Postoperative Nausea and Vomiting Opioid Use

UNKNOWN NA

Efficacy of Transversus Thoracis Muscle Plane Block in Patients Undergoing Cardiac Surgery

NCT06239025

Postoperative Pain

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Mangement of Thoracotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group CTB

n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25%

Group Type ACTIVE_COMPARATOR

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Group CTB (n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25% Group ESPB (n=30): patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%

Group ESPB

patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%

Group Type ACTIVE_COMPARATOR

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Group CTB (n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25% Group ESPB (n=30): patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine 0.25% Injectable Solution

Group CTB (n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25% Group ESPB (n=30): patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Age from 18 to 75 years old.

* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I-II-III.
* Patient undergoing unilateral thoracotomy surgery.

Exclusion Criteria

* • BMI more than 30 kg/m2.

* Patients who are taking analgesics for chronic illness or have a history of substance abuse.
* Patients who are unable to describe their postoperative pain (e.g., language barrier or neuropsychiatric disorder).
* Patients with a history of coagulopathy.
* Severe heart diseases.
* Hepatic or renal insufficiency.
* Infection at the site of infiltration

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No